Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Anesthesiol Clin ; 35(2): 207-219, 2017 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-28526143

RESUMO

Uterine atony is a common cause of primary postpartum hemorrhage, which remains a major cause of pregnancy-related mortality for women worldwide. Oxytocin, methylergonovine, carboprost, and misoprostol are commonly used to restore uterine tone. Oxytocin is the first-line agent. Methylergonovine and carboprost are both highly effective second-line agents with severe potential side effects. Recent studies have called into question the effectiveness of misoprostol as an adjunct to other uterotonic agents, but it remains a useful therapeutic in resource-limited practice environments. We review the current role these medications play in the prevention and treatment of uterine atony.


Assuntos
Carboprosta/uso terapêutico , Metilergonovina/uso terapêutico , Misoprostol/uso terapêutico , Ocitócicos/uso terapêutico , Ocitocina/uso terapêutico , Hemorragia Pós-Parto/tratamento farmacológico , Hemorragia Pós-Parto/prevenção & controle , Carboprosta/efeitos adversos , Feminino , Humanos , Metilergonovina/efeitos adversos , Misoprostol/efeitos adversos , Ocitócicos/efeitos adversos , Ocitocina/efeitos adversos , Gravidez
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...